Point-of-Care Infectious Disease Diagnostics Testing Market
Table of Contents
Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Value
2.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type
2.2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Value
2.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Sales
2.3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Sales by Type
2.3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Sales
3. The Major Driver of Point-of-Care Infectious Disease Diagnostics & Testing Industry
3.1 Historical & Forecast Global Point-of-Care Infectious Disease Diagnostics & Testing Sales and Revenue (2018-2028)
3.2 Largest Application for Point-of-Care Infectious Disease Diagnostics & Testing (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Point-of-Care Infectious Disease Diagnostics & Testing Market
4.1 Regional Market Size in Terms of Sales (2022 & 2028)
4.2 Regional Market Share in Terms of Revenue (2022 & 2028)
4.3 Concentration Ratio (CR5& CR10) of Point-of-Care Infectious Disease Diagnostics & Testing Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
5.1 Current and Estimated Sales Breakdown by Type (2018-2028)
5.2 Current and Estimated Sales Breakdown by Application (2018-2028)
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
6.1 Current and Estimated Sales Breakdown by Type (2018-2028)
6.2 Current and Estimated Sales Breakdown by Application (2018-2028)
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
7.1 Current and Estimated Sales Breakdown by Type (2018-2028)
7.2 Current and Estimated Sales Breakdown by Application (2018-2028)
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
8.1 Current and Estimated Sales Breakdown by Type (2018-2028)
8.2 Current and Estimated Sales Breakdown by Application (2018-2028)
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
9.1 Current and Estimated Sales Breakdown by Type (2018-2028)
9.2 Current and Estimated Sales Breakdown by Application (2018-2028)
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
10.1 Current and Estimated Sales Breakdown by Type (2018-2028)
10.2 Current and Estimated Sales Breakdown by Application (2018-2028)
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
11.1 Current and Estimated Sales Breakdown by Type (2018-2028)
11.2 Current and Estimated Sales Breakdown by Application (2018-2028)
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. South America Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
12.1 Current and Estimated Sales Breakdown by Type (2018-2028)
12.2 Current and Estimated Sales Breakdown by Application (2018-2028)
12.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
12.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
13. Global Point-of-Care Infectious Disease Diagnostics & Testing Average Price Trend
13.1 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in US (2018-2022)
13.2 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Europe (2018-2022)
13.3 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in China (2018-2022)
13.4 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Japan (2018-2022)
13.5 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in India (2018-2022)
13.6 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Korea (2018-2022)
13.7 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Southeast Asia (2018-2022)
13.8 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in South America (2018-2022)
14. Industrial Chain (Impact of COVID-19)
14.1 Point-of-Care Infectious Disease Diagnostics & Testing Industrial Chain Analysis
14.2 Downstream
14.3 Impact of COVID-19
14.4 Post-pandemic Era
14.5 Technology Trends of Point-of-Care Infectious Disease Diagnostics & Testing
15. Point-of-Care Infectious Disease Diagnostics & Testing Competitive Landscape
15.1 Abbott
15.1.1 Abbott Company Profiles
15.1.2 Abbott Product Introduction
15.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
15.1.4 Strategic initiatives
15.2 Thermo Fisher Scientific Inc
15.2.1 Thermo Fisher Scientific Inc Company Profiles
15.2.2 Thermo Fisher Scientific Inc Product Introduction
15.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
15.2.4 Strategic initiatives
15.3 Roche
15.3.1 Roche Company Profiles
15.3.2 Roche Product Introduction
15.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
15.3.4 Strategic initiatives
15.4 Siemens Healthineers
15.4.1 Siemens Healthineers Company Profiles
15.4.2 Siemens Healthineers Product Introduction
15.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
15.4.4 Strategic initiatives
15.5 BD & Company
15.5.1 BD & Company Company Profiles
15.5.2 BD & Company Product Introduction
15.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
15.5.4 Strategic initiatives
15.6 Chembio Diagnostics Inc.
15.6.1 Chembio Diagnostics Inc. Company Profiles
15.6.2 Chembio Diagnostics Inc. Product Introduction
15.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
15.6.4 Strategic initiatives
15.7 Trinity Biotech
15.7.1 Trinity Biotech Company Profiles
15.7.2 Trinity Biotech Product Introduction
15.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
15.7.4 Strategic initiatives
15.8 Cardinal Health
15.8.1 Cardinal Health Company Profiles
15.8.2 Cardinal Health Product Introduction
15.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
15.8.4 Strategic initiatives
15.9 Quest Diagnostics Inc.
15.9.1 Quest Diagnostics Inc. Company Profiles
15.9.2 Quest Diagnostics Inc. Product Introduction
15.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
15.9.4 Strategic initiatives
15.10 Bio-Rad Labs Inc.
15.10.1 Bio-Rad Labs Inc. Company Profiles
15.10.2 Bio-Rad Labs Inc. Product Introduction
15.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
15.10.4 Strategic initiatives
15.11 bioM?rieux SA
15.12 Sight Diagnostics Ltd.
15.13 Gene POC
15.14 Trivitron Healthcare
15.15 OJ-Bio Ltd.
15.16 Ortho-Clinical Diagnostics
16. Conclusion
17. Methodology and Data Source
List of Tables and Figures
Figure 1. Total Sales by Application of Point-of-Care Infectious Disease Diagnostics & Testing Industry (Volume)
Figure 2. Point-of-Care Infectious Disease Diagnostics & Testing Sales by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2028)
Figure 4. The Top 10 and 5 Players Market Share by Point-of-Care Infectious Disease Diagnostics & Testing Revenue in 2022
Figure 5. US Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
Figure 6. Sales Breakdown by Type (%)
Figure 7. Sales Breakdown by Type (%)
Figure 8. Sales Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
Figure 12. Sales Breakdown by Type (%)
Figure 13. Sales Breakdown by Type (%)
Figure 14. Sales Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
Figure 18. Sales Breakdown by Type (%)
Figure 19. Sales Breakdown by Type (%)
Figure 20. Sales Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
Figure 25. Sales Breakdown by Type (%)
Figure 26. Sales Breakdown by Type (%)
Figure 27. Sales Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
Figure 31. Sales Breakdown by Type (%)
Figure 32. Sales Breakdown by Type (%)
Figure 33. Sales Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
Figure 37. Sales Breakdown by Type (%)
Figure 38. Sales Breakdown by Type (%)
Figure 39. Sales Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Sales (2018-2028)
Figure 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Figure 44. Sales Breakdown by Type (%)
Figure 45. Sales Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Point-of-Care Infectious Disease Diagnostics & Testing Revenue, by Type (Million USD) (2018-2028)
Table 4. Point-of-Care Infectious Disease Diagnostics & Testing Sales, by Type (K Unit) (2018-2028)
Table 5. Point-of-Care Infectious Disease Diagnostics & Testing Sales (K Unit) by Application (2018-2028)
Table 6. Point-of-Care Infectious Disease Diagnostics & Testing Sales (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Sales (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2028)
Table 10. Ranking of Global Top Point-of-Care Infectious Disease Diagnostics & Testing Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Point-of-Care Infectious Disease Diagnostics & Testing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 13. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 14. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 15. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Point-of-Care Infectious Disease Diagnostics & Testing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 19. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 20. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 21. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Point-of-Care Infectious Disease Diagnostics & Testing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 25. Table Current and Estimated Sales Breakdown by Type
Table 26. Current and Estimated Sales Breakdown by Type
Table 27. Current and Estimated Sales Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Point-of-Care Infectious Disease Diagnostics & Testing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 30. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 31. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 32. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Point-of-Care Infectious Disease Diagnostics & Testing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 36. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 37. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 38. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Point-of-Care Infectious Disease Diagnostics & Testing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 42. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 43. Current and Estimated Sales Breakdown by Type (2018-2028)
Table 44. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Sales (K Unit), Market Revenue (Million USD) (2018-2028)
Table 48. Table Current and Estimated Sales Breakdown by Type (2018-2028)
Table 49. Current and Estimated Sales Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Abbott Profiles
Table 61. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 62. Abbott Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Abbott Strategic initiatives
Table 64. Thermo Fisher Scientific Inc Profiles
Table 65. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 66. Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. Thermo Fisher Scientific Inc Strategic initiatives
Table 68. Roche Profiles
Table 69. Roche Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 70. Roche Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Roche Strategic initiatives
Table 72. Siemens Healthineers Profiles
Table 73. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 74. Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Siemens Healthineers Strategic initiatives
Table 76. BD & Company Profiles
Table 77. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 78. BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. BD & Company Strategic initiatives
Table 80. Chembio Diagnostics Inc. Profiles
Table 81. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 82. Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Chembio Diagnostics Inc. Strategic initiatives
Table 84. Trinity Biotech Profiles
Table 85. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 86. Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Trinity Biotech Strategic initiatives
Table 88. Cardinal Health Profiles
Table 89. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 90. Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Cardinal Health Strategic initiatives
Table 92. Quest Diagnostics Inc. Profiles
Table 93. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 94. Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Quest Diagnostics Inc. Strategic initiatives
Table 97. Bio-Rad Labs Inc. Profiles
Table 98. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 99. Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. Bio-Rad Labs Inc. Strategic initiatives
Table 101. bioM?rieux SA Profiles
Table 102. bioM?rieux SA Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 103. bioM?rieux SA Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. bioM?rieux SA Strategic initiatives
Table 105. Sight Diagnostics Ltd. Profiles
Table 106. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 107. Sight Diagnostics Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. Sight Diagnostics Ltd. Strategic initiatives
Table 109. Gene POC Profiles
Table 110. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 111. Gene POC Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. Gene POC Strategic initiatives
Table 113. Trivitron Healthcare Profiles
Table 114. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 115. Trivitron Healthcare Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 116. Trivitron Healthcare Strategic initiatives
Table 117. OJ-Bio Ltd. Profiles
Table 118. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 119. OJ-Bio Ltd. Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 120. OJ-Bio Ltd. Strategic initiatives
Table 121. Ortho-Clinical Diagnostics Profiles
Table 122. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Product Introduction
Table 123. Ortho-Clinical Diagnostics Point-of-Care Infectious Disease Diagnostics & Testing Sales (Unit), Revenue (Million USD) (2018-2022)
Table 124. Ortho-Clinical Diagnostics Strategic initiatives
Industry Market Size
